Charles Conway

Biohaven Pharmaceutical Holding Co Ltd.

Chief Scientific Officer

Overview

Charles Conway made an average of $2.2M in compensation at Biohaven Pharmaceutical Holding Co Ltd. between 2017 and 2018.

Annual data

2018

In 2018, Charles Conway earned a total compensation of $2.8M as Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd..

Ranking3,434 out of 10,931
Percentile68.6%

Charles Conway's 2018 compensation ranked 3,434th out of 10,931 executive pay records tracked by us this year.

Conway earned more than 68.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking360 out of 1,243
Percentile71.0%

In the industry group of Drugs, Conway's pay ranked 360th out of 1,243 executive pay records tracked by us in 2018.

Conway earned more than 71.0% of executives in this group.

Bonus$205,163
Option Awards$2,243,800
Salary$334,960
Other$8,932
Total$2,792,855

Conway received $2.2M in option awards, which accounts for 80.34% of total compensation.

Conway also received $205.2K in bonus, $335K in salary and $8.9K in other compensation.

2017

In 2017, Charles Conway earned a total compensation of $1.6M as Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd..

Ranking6,204 out of 13,778
Percentile55.0%

Charles Conway's 2017 compensation ranked 6,204th out of 13,778 executive pay records tracked by us this year.

Conway earned more than 55.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking562 out of 1,566
Percentile64.1%

In the industry group of Drugs, Conway's pay ranked 562nd out of 1,566 executive pay records tracked by us in 2017.

Conway earned more than 64.1% of executives in this group.

Bonus$191,900
Option Awards$1,118,433
Salary$305,883
Other$9,932
Total$1,626,148

Conway received $1.1M in option awards, which accounts for 68.78% of total compensation.

Conway also received $191.9K in bonus, $305.9K in salary and $9.9K in other compensation.